Schellenberg Wittmer advises on Cardinal Health acquisition of Cordis
28 October 2015
Cardinal Health, Inc., a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products, completed the acquisition of Johnson & Johnson's Cordis business, a global leader in cardiology and endovascular devices, for USD 1,944 billion.
Schellenberg Wittmer acted as Swiss legal counsel to the buyer in all aspects of the transaction. The team consisted of partners Oliver Triebold
(overall lead, corporate/M&A), Philippe Ducor
(health regulatory/compliance), Vincent Carron
(employment), Josef Caleff
(real estate), counsel Christine Beusch-Liggenstorfer
(employment), senior associate Anne Roux-Fouillet
(employment) and associates Marcel Jakob
(real estate), Camillo Devecchi
(corporate/M&A) and Kaspar Theiler
(corporate/M&A, health regulatory/compliance).
Please see here for additional information.
Back to overview